Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001

Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001

<p>Kaplan-Meier curves for Event-free Survival (EFS) in each dose group</p>

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Yan Zhou (15053225) (author)
Rannpháirtithe:	Qingcheng Yang (15053228) (author), Yang Dong (15053231) (author), Tong Ji (15053234) (author), Bing Zhang (15053237) (author), Cheng Yang (15053240) (author), Shuier Zheng (15053243) (author), Lina Tang (15053246) (author), Chenliang Zhou (15053249) (author), Guowei Qian (15053252) (author), Yujing Huang (15053255) (author), Wenxi Yu (15053258) (author), Hongtao Li (15053261) (author), Yonggang Wang (15053264) (author), Aina He (15053267) (author), Zan Shen (15053270) (author), Qiyuan Bao (15053273) (author), Yingqi Hua (15053276) (author), Hongyu Bai (15053279) (author), Jiayi Zhao (15053282) (author), Xiaoyi Li (15053285) (author), Xiangrong Dai (15047025) (author), Jianjun Zhang (15053288) (author), Haiyan Hu (15053291) (author), Yang Yao (15053294) (author)
Foilsithe / Cruthaithe:	2025
Ábhair:	Cancer Therapeutic Research and Development Clinical Research and Trials Chemotherapy Clinical-Stage Research Sarcomas Osteosarcoma
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Kaplan-Meier curves of (A) progression-free survival and (B) overall survival.
de réir: Lu Xie (20428615)
Foilsithe / Cruthaithe: (2025)

Supplementary Data File 1 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
de réir: William Kelly (15439117)
Foilsithe / Cruthaithe: (2025)

Supplementary Data File 2 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
de réir: William Kelly (15439117)
Foilsithe / Cruthaithe: (2025)

Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
de réir: Amir T. Fathi (15313195)
Foilsithe / Cruthaithe: (2025)

Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
de réir: Amir T. Fathi (15313195)
Foilsithe / Cruthaithe: (2025)

Supplementary Data S1 from Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
de réir: Steven B. Maron (15044607)
Foilsithe / Cruthaithe: (2025)

Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
de réir: Alexander N. Shoushtari (15023909)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
de réir: Sanna Pikkusaari (15055802)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S2 from Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
de réir: Sanna Pikkusaari (15055802)
Foilsithe / Cruthaithe: (2025)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
de réir: Robert L. Hollis (15034814)
Foilsithe / Cruthaithe: (2025)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
de réir: Robert L. Hollis (15034814)
Foilsithe / Cruthaithe: (2025)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
de réir: Robert L. Hollis (15034814)
Foilsithe / Cruthaithe: (2025)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
de réir: Robert L. Hollis (15034814)
Foilsithe / Cruthaithe: (2025)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
de réir: Robert L. Hollis (15034814)
Foilsithe / Cruthaithe: (2025)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
de réir: Robert L. Hollis (15034814)
Foilsithe / Cruthaithe: (2025)

Supplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
de réir: Dhruv Chachad (14954640)
Foilsithe / Cruthaithe: (2025)

Supplementary Table 2 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
de réir: Dhruv Chachad (14954640)
Foilsithe / Cruthaithe: (2025)

Supplementary Table 3 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
de réir: Dhruv Chachad (14954640)
Foilsithe / Cruthaithe: (2025)

Supplementary Table 4 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
de réir: Dhruv Chachad (14954640)
Foilsithe / Cruthaithe: (2025)

Supplementary Table 5 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
de réir: Dhruv Chachad (14954640)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma
de réir: Jun Wang (15051911)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
de réir: Raphaël Leman (17314506)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
de réir: Raphaël Leman (17314506)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
de réir: Raphaël Leman (17314506)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
de réir: Raphaël Leman (17314506)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S5 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
de réir: Raphaël Leman (17314506)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S6 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
de réir: Raphaël Leman (17314506)
Foilsithe / Cruthaithe: (2025)

Comparison of Severity Grade and Normal EMG Between First and Second EMG Assessments in dialysis group at T2.
de réir: Arwa Yahyaoui (22683276)
Foilsithe / Cruthaithe: (2025)

Supplementary Video S1 from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
de réir: Xiaojiang Duan (15439264)
Foilsithe / Cruthaithe: (2025)

Supplementary Video S2A from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
de réir: Xiaojiang Duan (15439264)
Foilsithe / Cruthaithe: (2025)

Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
de réir: Xiaojiang Duan (15439264)
Foilsithe / Cruthaithe: (2025)

Supplementary Video S2C from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
de réir: Xiaojiang Duan (15439264)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S1 from A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors: Two-Year Outcomes
de réir: Benjamin K. Wilke (15055112)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S2 from A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors: Two-Year Outcomes
de réir: Benjamin K. Wilke (15055112)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S1 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
de réir: Arathi Mohan (15561346)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S4 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
de réir: Arathi Mohan (15561346)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
de réir: Tom Wei-Wu Chen (15053003)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
de réir: Tom Wei-Wu Chen (15053003)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
de réir: Tom Wei-Wu Chen (15053003)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
de réir: Tom Wei-Wu Chen (15053003)
Foilsithe / Cruthaithe: (2025)

Cannot write session to /tmp/vufind_sessions/sess_5505gepak0aovp89q56pl4bbtc